Life Sciences

BoxGroup

Check: BoxGroup currently publishes a firm-wide maximum investment of $1M. Historical sources reported smaller firm checks and third-party profiles estimate $250K–$750K for Nimi, but no primary source confirms a current personal range.

Nimi is a generalist early-stage Partner with a long-running, publicly documented focus on healthcare and life sciences, fintech, marketplaces, and software. Her current activity extends that lens into AI-native healthcare, scientific agents, enterprise AI, and the financial infrastructure surrounding AI use. She applies BoxGroup's founder-first philosophy while testing whether the operating model, retention, sequencing, and economics can support the founder's category-scale ambition.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Linda Olson is listed in a Office Manager capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

INITIATE Ventures

Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.

Jessica Owens invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Shelly Lanning invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Becky Hoerman is listed in a Controller capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

INITIATE Ventures

Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.

Iana Dimkova invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Melinda Gloriosa invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Justin Probst is listed in a Vice President, Finance and Operations capacity at R1 Capital. The firm does not publish a person-specific investment thesis for this role; the profile therefore preserves the role distinction and uses the firm's public mandate only as shared context.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Meghan Hoffman invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Riley Shelton invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Grant Berliner invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Parker MacDonell invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Wayne Embree invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Kim Garland invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Srini Koushik invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Greylock Partners

Check: No current personal or Greylock check range is attributable to Howard, and his emeritus Special Limited Partner status should not be treated as current check-writing authority. Contact Greylock's active investors for stage, allocation, ownership and process.

Howard's record reflects a long-horizon institution-builder and governance lens developed across Greylock, the NVCA, In-Q-Tel, Stryker, investment committees and public-interest institutions. It is useful for evaluating leadership, board quality, stewardship and the relationship between private innovation and enduring institutions, but it is historical/advisory—not a current personal sourcing thesis.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Shahram Seyedin-Noor invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Sonia Setayesh invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Manuel Lopez-Figueroa invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Sarah Loveland invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Angelica Parente invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Omar Yamout invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Carli Kaleta invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.

Civilization Ventures

Check: Civilization Ventures does not publish a standard check-size range on its official site.

Matt Wheeler is listed in a CFO capacity at Civilization Ventures. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Mark Gorenberg invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Apoorva Pandhi invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Jocelyn Goldfein invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Dylan Reid invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Zetta Venture Partners

Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.

Annelies Gamble invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Scott Addonizio is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Verlensia Bates is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Will Cadell is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Andy Dearing is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Joel Crater is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Caleb Eidem is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Scott Herman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Elise Miller Hoffman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Cliff Holekamp is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kristina Hood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kyle Kerns is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Catherine Matthes is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Brian Matthews is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Paul Meier is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Sean Morris is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Dennis Muilenburg is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

David Narrow is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Matt Phimphavong is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Grant Pothast is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Rick Ryan is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Bobby Sandage is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Martha Schlicher is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Barry Sandweiss is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Bill Schmidt is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

David Smoller is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Timothy Stern is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

John True is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Paul Weber is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Kyle Welborn is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

Cultivation Capital

Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.

Heather Wood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ben Patz is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Kathy Chiu is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Mitchel Laskey is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ken Hall is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Jackson Streeter, MD is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

DeepWork Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Kristopher Lancaster is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Stacey Barnes is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Henry Haverty is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Logan Hille, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Kerry Hull, CPA, MBA is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Sean Kwiat is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Liam McAllister is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Bryan McCleary is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Kenneth Morand, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

CincyTech

Check: The firm does not publish a person-specific check-size range on its current official website.

Emma Off is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Maureen Stancik Boyce, PhD is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Amy Salzhauer is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Carolyne LaSala is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

David Mendez is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Sophie Hagerty is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Aditi Rajagopal is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Good Growth Capital

Check: The firm does not publish a person-specific check-size range on its current official website.

Ziad Sarby is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Marc Averitt invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Jeff Bocan invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

John Waller invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

Okapi Venture Capital

Check: Okapi Venture Capital does not publish a standard check-size range on its official site.

Sharon Stevenson invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Hayes Barnes is listed in a Director of Marketing capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Marli Carmack is listed in a Office Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Andie Hines-Lagemann invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Chris Huxhold is listed in a Chief Financial Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Brighid King is listed in a Platform Operations Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Nicholas Kuhn invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Phil Lodato is listed in a General Counsel and Chief Compliance Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Makenzie Norris invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Jacob Schpok is listed in a Partner and Head of Platform capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Erica Schweyer is listed in a Chief of Staff capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Muhammad Yasin is listed in a Chief Marketing Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Landon Young invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Paul D'Amato invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Jody Vanderwel invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Dale Grogan invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Meagan Malm is listed in a Partner and Director of Operations capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Lynn Bishop invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Emily Sarata invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Kalina Foster is listed in a Platform Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Roshan Atluri is listed in a Senior Software Engineer and IT Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Simran Kalra invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Savannah Tuttle is listed in a Executive Assistant and Operations Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Khushi Gupta invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Nader Motamedy invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Jeff Wesley invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Pete Martin invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Matt Okoneski invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Tommy Skinner invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Karis D'Alessandro invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Moody Mattan invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Vikram Mohan invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Calvin VanderWal invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful operations and job creation in Michigan.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Arunas Chesonis invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Nichole Maguire is listed in a Venture Coordinator capacity at Michigan Rise. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Sahba Vaziri is listed in a Partner, CFO, Investment Committee Member capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Piyush Bharti invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Tim Bowe invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Rob Fleischman invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Roberta Sydney invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Vera Schroeder invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Parinaz Motamedy invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Arda Kotikian invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Leslie Hartford is listed in a Manager of Administration capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Tony Cheung is listed in a Manager of Systems & Operations capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Hannah Jacobs invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Safar Partners

Check: Safar Partners does not publish a standard check-size range on its official site.

Andy Cohen invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sciences from inception through scale.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Toph Day invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Myles Grote invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Drew Hannel invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Jay Harmas invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Asa Kelly is listed in a Vice President of Investment Operations and Portfolio Analytics capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Cy Megnin invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Patrick Sweeney invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Matt Tyner invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Ben Weber is listed in a Senior Accountant capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Elevate Ventures

Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.

Logan White invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Ryan Ellis is listed in a Chief Financial Officer capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Jenni Li invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Abid Ali invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Jake Standerfer is listed in a Controller capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Abiola Olatoye invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.

Michigan Capital Network

Check: Michigan Capital Network does not publish a standard current check-size range on its official site.

Greeshma Muddam is listed in a Accountant capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Michigan Rise

Check: Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.

Abdel Diab is listed in a Data Analyst capacity at Michigan Rise. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Charlie Hipwood contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Vinit Nijhawan contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Priya Yadav contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Stacy Swider contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Myron Kassaraba contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Sienna Leis contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Whitney Leslie contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

MassVentures

Check: MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.

Matt Snow contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovation economy.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

David Michael contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

David Seldin contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Whitney Haring-Smith contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Debrah Herman, CPA contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jimmy Kan, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

William H. Strong contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Michael Burychka contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jason Smith, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jenna Abelli contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Henk Both, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Josh Stiling contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Brandon Fleischman contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Daniel Hirsch contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Steven Battista contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jennifer Ting contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Rebecca Chimwanda contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Beverly Himes, CPA contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

John Sears, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Wendy Papakostandini contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Kalyn Schieffer contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jordan Borawski contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jacquelyn Brown contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Jerry Carlisle Jr. contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Madi Casey contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Symone Collins contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Victoria DiGiustino contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Neika Fatehi contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Angela Feller contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Claudia Gau contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Latoya Green contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Patrick Irvan contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Melissa Johnson contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Kaitlyn Lagasca contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Kyle Manning contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Katie Messner contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Rebecca Parcher contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Wilson Poole contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Emma Ramrattan contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Lex Smith contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Lori Swann contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners

Check: Anzu Partners does not publish a standard check-size range on its current official website.

Ittie Rehani contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Tom Walker invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

R1 Capital

Check: R1 Capital does not publish a standard person-specific check-size range on its current website.

Ryan Helon invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.

Big Pi Ventures

Check: €500K-€3M initial investments for Melina's early-stage work; Big Pi's wider family-of-funds range extends to €30M.

Melina invests in early-stage AI, robotics, B2B SaaS, life sciences, and climate technology. Her engineering and deep-learning background supports technical diligence, while her strategy-and-operations experience informs evaluation of commercial paths, deal structure, and the practical support a technical founding team needs after investment.

Anzu Partners

Boston / San Diego / Tampa / Washington, DC / Atlanta

AUM: Approximately $1B

Cultivation Capital

St. Louis, Missouri

Elevate Ventures

Indianapolis, Indiana

Michigan Capital Network

Grand Rapids, Michigan

Safar Partners

Cambridge, Massachusetts

Clarevia

Madison, Wisconsin

R1 Capital

Columbus, Ohio

Michigan Rise

East Lansing, Michigan

CincyTech

Cincinnati, Ohio

Civilization Ventures

San Francisco, California

MassVentures

Waltham, Massachusetts / Worcester, Massachusetts

DeepWork Capital

Orlando, Florida

Good Growth Capital

Charleston, South Carolina

Okapi Venture Capital

Newport Beach, California

Zetta Venture Partners

San Francisco, California

INITIATE Ventures

United States